JAZZ vs STHO · P/E 1988, rev $2.28B vs rev $110.1M
Jazz Pharmaceuticals PLC (JAZZ) versus Star Holdings (STHO) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Star Holdings (STHO) is a real estate services company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported STHO revenue for 2025-12-31 was $110.1M. Net income was -$64.2M. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. STHO currently screens at market cap $107.5M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. STHO currently screens at market cap $107.5M.
Not investment advice. Open the JAZZ and STHO stock pages for the full models.
Not investment advice.